Ligand validation:8SDV

ZXM: 1-{(2R)-2-(dihydroxyboranyl)-2-[(thiophen-2-ylacetyl)amino]ethyl}-1H-1,2,3-triazole-4-carboxylic acid

ZXM is a Ligand Of Interest in 8SDV designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8SDV_ZXM_A_402	57%	32%	0.128	0.901	0.89	1.78	1	3	1	0	100%	0.7659
8SDT_ZXM_A_402	91%	13%	0.08	0.967	1.83	2.12	5	3	0	0	100%	0.8773
5EE8_ZXM_A_301	87%	21%	0.086	0.959	1.09	2.22	1	5	0	0	100%	0.8864
5EEC_ZXM_A_301	77%	26%	0.104	0.943	1.37	1.62	3	4	1	0	100%	0.7545
4U0X_ZXM_B_401	64%	13%	0.12	0.918	1.65	2.3	3	6	1	0	100%	1
5ZYB_ZXM_A_401	11%	35%	0.247	0.77	1.09	1.44	2	2	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.